However, for the first time, our study highlights the significance of tumor-suppressing miR-23b-3p in modulating cytoprotective autophagy through ATG12 and glutamine addiction through GLS1 in sorafenib-resistant HCC. The gene discussed is GLS; the disease is hepatocellular carcinoma.